138 related articles for article (PubMed ID: 26278348)
1. Potential of boron neutron capture therapy (BNCT) for malignant peripheral nerve sheath tumors (MPNST).
Fujimoto T; Andoh T; Sudo T; Fujita I; Fukase N; Takeuchi T; Sonobe H; Inoue M; Hirose T; Sakuma T; Moritake H; Sugimoto T; Kawamoto T; Fukumori Y; Yamamoto S; Atagi S; Sakurai Y; Kurosaka M; Ono K; Ichikawa H; Suzuki M
Appl Radiat Isot; 2015 Dec; 106():220-5. PubMed ID: 26278348
[TBL] [Abstract][Full Text] [Related]
2. Boron neutron capture therapy as new treatment for clear cell sarcoma: trial on different animal model.
Andoh T; Fujimoto T; Sudo T; Suzuki M; Sakurai Y; Sakuma T; Moritake H; Sugimoto T; Takeuchi T; Sonobe H; Epstein AL; Fukumori Y; Ono K; Ichikawa H
Appl Radiat Isot; 2014 Jun; 88():59-63. PubMed ID: 24389062
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: Trial using a lung metastasis model of CCS.
Andoh T; Fujimoto T; Suzuki M; Sudo T; Sakurai Y; Tanaka H; Fujita I; Fukase N; Moritake H; Sugimoto T; Sakuma T; Sasai H; Kawamoto T; Kirihata M; Fukumori Y; Akisue T; Ono K; Ichikawa H
Appl Radiat Isot; 2015 Dec; 106():195-201. PubMed ID: 26337135
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model.
Fujimoto T; Andoh T; Sudo T; Fujita I; Moritake H; Sugimoto T; Sakuma T; Akisue T; Kawabata S; Kirihata M; Suzuki M; Sakurai Y; Ono K; Fukumori Y; Kurosaka M; Ichikawa H
Appl Radiat Isot; 2013 Mar; 73():96-100. PubMed ID: 23306161
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy for clear cell sarcoma (CCS): biodistribution study of p-borono-L-phenylalanine in CCS-bearing animal models.
Andoh T; Fujimoto T; Sudo T; Fujita I; Imabori M; Moritake H; Sugimoto T; Sakuma Y; Takeuchi T; Kawabata S; Kirihata M; Akisue T; Yayama K; Kurosaka M; Miyatake S; Fukumori Y; Ichikawa H
Appl Radiat Isot; 2011 Dec; 69(12):1721-4. PubMed ID: 21367607
[TBL] [Abstract][Full Text] [Related]
6. Experimental Studies of Boronophenylalanine ((10)BPA) Biodistribution for the Individual Application of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma Treatment.
Carpano M; Perona M; Rodriguez C; Nievas S; Olivera M; Santa Cruz GA; Brandizzi D; Cabrini R; Pisarev M; Juvenal GJ; Dagrosa MA
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):344-52. PubMed ID: 26232853
[TBL] [Abstract][Full Text] [Related]
7. Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter.
Miyabe J; Ohgaki R; Saito K; Wei L; Quan L; Jin C; Liu X; Okuda S; Nagamori S; Ohki H; Yoshino K; Inohara H; Kanai Y
J Pharmacol Sci; 2019 Mar; 139(3):215-222. PubMed ID: 30833090
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of BPA uptake in clear cell sarcoma (CCS) in vitro and development of an in vivo model of CCS for BNCT studies.
Fujimoto T; Andoh T; Sudo T; Fujita I; Imabori M; Moritake H; Sugimoto T; Sakuma Y; Takeuchi T; Sonobe H; Epstein AL; Akisue T; Kirihata M; Kurosaka M; Fukumori Y; Ichikawa H
Appl Radiat Isot; 2011 Dec; 69(12):1713-6. PubMed ID: 21354804
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
10. 4-Borono-2-
Ishiwata K
Ann Nucl Med; 2019 Apr; 33(4):223-236. PubMed ID: 30820862
[TBL] [Abstract][Full Text] [Related]
11. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
12. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive estimation of
Yoshimoto M; Honda N; Kurihara H; Hiroi K; Nakamura S; Ito M; Shikano N; Itami J; Fujii H
Cancer Sci; 2018 May; 109(5):1617-1626. PubMed ID: 29498142
[TBL] [Abstract][Full Text] [Related]
14. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.
Aromando RF; Trivillin VA; Heber EM; Pozzi E; Schwint AE; Itoiz ME
Oral Oncol; 2010 May; 46(5):355-9. PubMed ID: 20308008
[TBL] [Abstract][Full Text] [Related]
15. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
16. The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model.
Takahara K; Inamoto T; Minami K; Yoshikawa Y; Takai T; Ibuki N; Hirano H; Nomi H; Kawabata S; Kiyama S; Miyatake S; Kuroiwa T; Suzuki M; Kirihata M; Azuma H
PLoS One; 2015; 10(9):e0136981. PubMed ID: 26325195
[TBL] [Abstract][Full Text] [Related]
17. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution of boron after intravenous 4-dihydroxyborylphenylalanine-fructose (BPA-F) infusion in meningioma and schwannoma patients: A feasibility study for boron neutron capture therapy.
Kulvik M; Kallio M; Laakso J; Vähätalo J; Hermans R; Järviluoma E; Paetau A; Rasilainen M; Ruokonen I; Seppälä M; Jääskeläinen J
Appl Radiat Isot; 2015 Dec; 106():207-12. PubMed ID: 26298436
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy for hepatocellular carcinoma by boric acid-mediated boron neutron capture therapy in a rat model.
Lin SY; Lin CJ; Liao JW; Peir JJ; Chen WL; Chi CW; Lin YC; Liu YM; Chou FI
Anticancer Res; 2013 Nov; 33(11):4799-809. PubMed ID: 24222116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
